1. Vaccines Market Executive Summary2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction
6.1. Segmentation By Geography
6.2. Segmentation By Type
6.3. Segmentation By Technology
6.4. Segmentation By Route of Administration
6.5. Segmentation By Valance
6.6. Segmentation By Distribution Channel
7. Vaccines Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Type
7.2.1. Anti-Infective Vaccines
7.2.2. Anti-Cancer Vaccines
7.2.3. Others
7.3. Market Segmentation By Technology
7.3.1. Conjugate Vaccines
7.3.2. Inactivated And Subunit Vaccines
7.3.3. Live Attenuated Vaccines
7.3.4. Recombinant Vaccines
7.3.5. Toxoid Vaccines
7.3.6. Other Technologies
7.4. Market Segmentation By Route Of Administration
7.4.1. Intramuscular (IM)
7.4.2. Subcutaneous (SC)
7.4.3. Oral
7.4.4. Other Route of Administration
7.5. Market Segmentation By Valance
7.5.1. Monovalent
7.5.2. Multivalent
7.6. Market Segmentation By Distribution Channel
7.6.1. Hospital Pharmacies
7.6.2. Retail Pharmacies
7.6.3. Institutional Sales
8. Vaccines Market Trends And Strategies
8.1. Synthetic Biology In Vaccine Development
8.2. Development Of Combination Vaccines
8.3. Robust Research And Development
8.4. Increasing Demand For Conjugate Vaccines
8.5. Artificial Intelligence In Vaccine Development
8.6. mRNA Vaccines
8.7. Cancer Vaccines
9. Impact Of COVID-19 On The Vaccines Market
9.1. Introduction
9.2. Disruptions In Regular Vaccination Campaigns
9.3. Government Measures And Support For The Development Of Vaccines
9.4. COVID-19 Vaccines And Vaccination Strategies
9.5. Delay In COVID-19 Vaccine Development Activities
9.6. Future Outlook
10. Global Vaccines Market Size And Growth
10.1. Market Size
10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)
10.2.1. Drivers Of The Market 2015 – 2020
10.2.2. Restraints On The Market 2015 – 2020
10.3. Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
10.3.1. Drivers Of The Market 2020 – 2025
10.3.2. Restraints On The Market 2020 – 2025
11. Global Vaccines Market Segmentation
11.1. Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
11.2. Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
11.3. Global Vaccines Market, Segmentation By Route of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
11.3.1. Intramuscular (IM) Route Of Administration
11.3.2. Subcutaneous (SC) Route Of Administration
11.3.3. Other Route Of Administration
11.3.4. Oral Route Of Administration
11.4. Global Vaccines Market, Segmentation By Valance, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
11.4.1. Multivalent
11.4.2. Monovalent
11.5. Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Institutional Sale
12. Vaccines Market, Regional And Country Analysis
12.1. Global Vaccines Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
12.2. Global Vaccines Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13. Asia-Pacific Vaccines Market
13.1. Asia-Pacific Vaccines Market Overview
13.1.1. Region Information
13.1.2. Market Information
13.1.3. COVID-19 Impact
13.1.4. Background Information
13.1.5. Government Initiatives
13.1.6. Regulations
13.1.7. Regulatory Bodies
13.1.8. Major Associations
13.1.9. Investments
13.1.10. Taxes Levied
13.1.11. Corporate Tax Structure
13.1.12. Major Companies
13.2. Asia-Pacific Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.3. Asia-Pacific Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
13.4. Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.5. Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.6. Asia-Pacific Vaccines Market: Country Analysis
13.7. China Vaccines Market
13.8. China Vaccines Market Overview
13.8.1. Country Information
13.8.2. Market Information
13.8.3. COVID-19 Impact
13.8.4. Background Information
13.8.5. Government Initiatives
13.8.6. Regulations
13.8.7. Regulatory Bodies
13.8.8. Major Associations
13.8.9. Investments
13.8.10. Taxes Levied
13.8.11. Corporate Tax Structure
13.8.12. Major Companies
13.9. China Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.10. China Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
13.11. China Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.12. China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.13. India Vaccines Market
13.14. India Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.15. India Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
13.16. India Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.17. India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.18. Japan Vaccines Market
13.19. Japan Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.20. Japan Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
13.21. Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.22. Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.23. Australia Vaccines Market
13.24. Australia Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.25. Australia Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
13.26. Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.27. Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.28. Indonesia Vaccines Market
13.29. Indonesia Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.30. Indonesia Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
13.31. Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.32. Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.33. South Korea Vaccines Market
13.34. South Korea Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.35. South Korea Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
13.36. South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.37. South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14. Western Europe Vaccines Market
14.1. Western Europe Vaccines Market Overview
14.1.1. Region Information
14.1.2. Market Information
14.1.3. COVID-19 Impact
14.1.4. Background Information
14.1.5. Government Initiatives
14.1.6. Regulations
14.1.7. Regulatory Bodies
14.1.8. Major Associations
14.1.9. Taxes Levied
14.1.10. Corporate Tax Structure
14.1.11. Investments
14.1.12. Major Companies
14.2. Western Europe Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
14.3. Western Europe Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
14.4. Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.5. Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.6. Western Europe Vaccines Market: Country Analysis
14.7. UK Vaccines Market
14.8. UK Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
14.9. UK Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
14.10. UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.11. UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.12. Germany Vaccines Market
14.13. Germany Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
14.14. Germany Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
14.15. Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.16. Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.17. France Vaccines Market
14.18. France Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
14.19. France Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
14.20. France Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.21. France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
15. Eastern Europe Vaccines Market
15.1. Eastern Europe Vaccines Market Overview
15.1.1. Region Information
15.1.2. Market Information
15.1.3. COVID-19 Impact
15.1.4. Background Information
15.1.5. Government Initiatives
15.1.6. Regulations
15.1.7. Regulatory Bodies
15.1.8. Major Associations
15.1.9. Investments
15.1.10. Taxes Levied
15.1.11. Corporate Tax Structure
15.1.12. Major Companies
15.2. Eastern Europe Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
15.3. Eastern Europe Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
15.4. Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
15.5. Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
15.6. Eastern Europe Vaccines Market: Country Analysis
15.7. Russia Vaccines Market
15.8. Russia Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
15.9. Russia Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
15.10. Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
15.11. Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
16. North America Vaccines Market
16.1. North America Vaccines Market Overview
16.1.1. Region Information
16.1.2. Market Information
16.1.3. COVID-19 Impact
16.1.4. Background Information
16.1.5. Government Initiatives
16.1.6. Regulations
16.1.7. Regulatory Bodies
16.1.8. Major Associations
16.1.9. Corporate Tax Structure
16.1.10. Taxes Levied
16.1.11. Investments
16.1.12. Major Companies
16.2. North America Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
16.3. North America Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
16.4. North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
16.5. North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
16.6. North America Vaccines Market: Country Analysis
16.7. USA Vaccines Market
16.8. USA Vaccines Market Overview
16.8.1. Country Information
16.8.2. Market Information
16.8.3. COVID-19 Impact
16.8.4. Background Information
16.8.5. Government Initiatives
16.8.6. Regulations
16.8.7. Regulatory Bodies
16.8.8. Major Associations
16.8.9. Corporate Tax Structure
16.8.10. Taxes Levied
16.8.11. Investments
16.8.12. Major Companies
16.9. USA Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
16.10. USA Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
16.11. USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
16.12. USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
17. South America Vaccines Market
17.1. South America Vaccines Market Overview
17.1.1. Region Information
17.1.2. Market Information
17.1.3. Impact of COVID-19
17.1.4. Background Information
17.1.5. Government Initiatives
17.1.6. Regulations
17.1.7. Regulatory Bodies
17.1.8. Major Associations
17.1.9. Taxes Levied
17.1.10. Corporate Tax Structure
17.1.11. Investments
17.1.12. Major Companies
17.2. South America Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
17.3. South America Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
17.4. South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
17.5. South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
17.6. South America Vaccines Market: Country Analysis
17.7. Brazil Vaccines Market
17.8. Brazil Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
17.9. Brazil Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
17.10. Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
17.11. Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18. Middle East Vaccines Market
18.1. Middle East Vaccines Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. Impact of COVID-19
18.1.4. Background Information
18.1.5. Government Initiatives
18.1.6. Regulatory Bodies
18.1.7. Regulations
18.1.8. Major Associations
18.1.9. Taxes Levied
18.1.10. Corporate Tax Structure
18.1.11. Investments
18.1.12. Major Companies
18.2. Middle East Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
18.3. Middle East Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
18.4. Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.5. Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19. Africa Vaccines Market
19.1. Africa Vaccines Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. COVID-19 Impact
19.1.4. Background Information
19.1.5. Government Initiatives
19.1.6. Regulations
19.1.7. Regulatory Bodies
19.1.8. Major Associations
19.1.9. Taxes Levied
19.1.10. Corporate Tax Structure
19.1.11. Investments
19.1.12. Major Companies
19.2. Africa Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.3. Africa Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
19.4. Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.5. Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
20. Global Vaccines Market Competitive Landscape
20.1. Company Profiles
20.2. GlaxoSmithKline plc
20.2.1. Company Overview
20.2.2. Products And Services
20.2.3. Business Strategy
20.2.4. Financial Overview
20.3. Merck & Co., Inc.
20.3.1. Company Overview
20.3.2. Products And Services
20.3.3. Business Strategy
20.3.4. Financial Overview
20.4. Sanofi S.A.
20.4.1. Company Overview
20.4.2. Products And Services
20.4.3. Business Strategy
20.4.4. Financial Overview
20.5. Pfizer Inc.
20.5.1. Company Overview
20.5.2. Products And Services
20.5.3. Business Strategy
20.5.4. Financial Overview
20.6. CSL Limited
20.6.1. Company Overview
20.6.2. Products And Services
20.6.3. Business Strategy
20.6.4. Financial Overview
21. Vaccines Pipeline Analysis
22. Key Mergers And Acquisitions In The Vaccines Market
22.1. Sanofi S.A. Acquired Kymab Ltd
22.2. BioNTech SE Acquired GMP Certified Manufacturing Site Of Novartis AG
22.3. GlaxoSmithKline plc Acquired 10% Stake In CureVac For $163.67 million
22.4. Novavax, Inc. Acquired Praha Vaccines For $167 million
22.5. Bavarian Nordic A/S Acquired Global Rights For Two Vaccines from GSK For $940.07 Million
22.6. Bharat Biotech International Limited Acquired Chiron Behring Vaccines From GlaxoSmithKline
22.7. Emergent BioSolutions Inc. Acquired PaxVax Corporation For $270 Million
22.8. Sanofi Pasteur Acquired Protein Sciences
23. Vaccines Market Future Outlook and Potential Analysis
23.1. Global Vaccines Market In 2025 – Countries Offering Most New Opportunities
23.2. Global Vaccines Market In 2025 – Segments Offering Most New Opportunities
23.3. Global Vaccines Market In 2025 – Growth Strategies
23.3.1. Market Trend Based Strategies
23.3.2. Competitor Strategies
24. Appendix
24.1. Market Data Sources
24.2. Research Methodology
24.3. Currencies
24.4. Research Inquiries
24.5. The Business Research Company
24.6. Copyright And Disclaimer